Thursday, 9 October 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 9 October 2025
Ascott 2
Ascott 2
How much Aussie pharmas earn

The Australian Tax Office has released this year's Corporate Transparency Reports, revealing just how much Big Pharma companies are making in Australia.

Novartis reshuffles leaders
After a high-profile exit and the return of a country leader, Novartis rejigs some of the company's most senior ANZ roles
TODAY
AZ unveils next oncology move
MSAC application reveals the company's next move in lung cancer and confirms it will seek reimbursement on the PBS
TODAY
Samson Specialty
Samson Specialty
Who's disappearing from pharma?
This small, top-level cohort has taken a substantial hit with two-thirds of its ranks vanishing in just one week
8 October
Patients name favourite Big Pharma
Diabetes patient groups have ranked industry's best companies when it comes to corporate reputation
8 October
Aussies sue over 'ineffective' drugs
Company defends class action in the Federal Court over products it's claimed did not provide clinically significant benefit
7 October
Pharma failing at work-life balance?
Former pharma exec-turned best-selling author and coach, offers a solution to those feeling the work-life balance strain
7 October
Medscape
Medscape
Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (29)

Clinical & Medical, R&D (10)

Regulatory, Pharmacovigilance & QA (2)

Devices (1)

Executive Roles (1)

Other (14)

Call for new medicines pathway
Soaring prescriptions prompts proposal for a new ARTG product listing category to ensure safety, quality and efficacy
8 October
Third time lucky at PBAC?
November Agenda update reveals this company is going another round with PBAC, its third attempt this year
8 October
Meet MA's newest member
Industry body welcomes a new pharma looking to strengthen partnerships and contribute to patient-focused healthcare
8 October
FDA lifts hold on Aussie drug
After 10 months in limbo, the FDA's change of heart clears the way for promising flagship drug to enter Phase 2/3 trials this year
7 October
Faster access boosts productivity
Summit unpacks the link between speedy access to innovative treatments and national productivity
7 October
PBAC hopefuls score TGA wins
One new drug and two new forms of already approved medicines have been listed on the ARTG
7 October Approvals Action
Expat home for Country Lead job
Seventh country head to leave Australia in the last three months with her replacement already named
3 October
Pharma PR campaigns up for gongs
The shortlist for the prestigious Golden Target Awards feature pharma campaigns and the agencies they work with
3 October
'No thanks' to Govt PBS offer
ICYMI: Another company walks away from PBS negotiations plus the other most popular stories this week
3 October Your Week in 5 Minutes
Testing competency in Med Affairs
Locally developed framework defines competency levels of medical affairs work, allowing professionals to demonstrate value they bring to pharma
3 October
Long-running shortage rolls on
Manufacturing problems the cause of a shortage which saw supply of this critical drug dry up in 2023
3 October
Aussie pharma's 5 best workplaces
Which companies have made Great Place to Work's prestigious top pharma and biotechs in ANZ list?
2 October
Is culture crumbling in pharma?
Industry report find more than half of employees believe their workplace culture is only moderately healthy... or worse
2 October
Old drug on road to reinvention
Century old drug, normally administered by injection, halves the risk of death by respiratory infection when inhaled
2 October
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.